Milestone Scientific Reports Financial Results for Third Quarter 2026

Medical Segment Revenue Grows 136% Year-Over-Year Expands CompuFlo® Physician Partnerships and Advances Medical Commercialization Online Demonstrations More Than Double Reflecting Increased Customer Engagement Reaffirms 2026 Outlook for Double-Digit Revenue Growth, Including Significant Growth in CompuFlo® Sales Identifies approximately $400,000 in Additional Annual Savings, Supporting Expectation to Approach or Achieve Profitability in Fourth Quarter 2026 and Additional Profitable Quarters in 2027 ROSELAND ...

Milestone Scientific Reports Financial Results for Third Quarter 2026 - Reportify